HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria Prins Selected Research

Hepatitis

6/2021A Feasibility Study to Increase Chronic Hepatitis C Virus RNA Testing and Linkage to Care among Clients Attending Homeless Services in Amsterdam, The Netherlands.
4/2013Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997.
2/2008Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria Prins Research Topics

Disease

64Infections
02/2024 - 02/2002
20Acquired Immunodeficiency Syndrome (AIDS)
01/2019 - 10/2002
19Sexually Transmitted Diseases (Sexually Transmitted Disease)
05/2024 - 01/2011
19HIV Infections (HIV Infection)
11/2023 - 03/2003
11HIV Seropositivity
01/2019 - 10/2002
10Hepatitis C
01/2023 - 10/2010
9Reinfection
02/2024 - 11/2011
8Disease Progression
01/2012 - 11/2004
7COVID-19
02/2024 - 01/2021
6Coinfection
01/2024 - 04/2013
5Viremia
01/2017 - 03/2015
4Inflammation (Inflammations)
01/2023 - 12/2014
4Hepatitis B
11/2021 - 01/2016
4Cognitive Dysfunction
08/2017 - 01/2016
3Liver Diseases (Liver Disease)
01/2024 - 07/2010
3Hepatitis
06/2021 - 02/2008
3Cardiovascular Diseases (Cardiovascular Disease)
01/2017 - 08/2009
2Fever (Fevers)
01/2019 - 11/2017
2Frailty
01/2018 - 01/2016
2Lymphogranuloma Venereum
11/2017 - 02/2008
2Opportunistic Infections (Opportunistic Infection)
03/2016 - 03/2006
2Neoplasms (Cancer)
01/2014 - 03/2005
1Post-Acute COVID-19 Syndrome
06/2023
1Neuroinflammatory Diseases
01/2023
1Malaria
09/2022
1Mpox (monkeypox)
01/2022
1Virus Diseases (Viral Diseases)
11/2021
1Persistent Infection
01/2021
1Chronic Hepatitis B
01/2020
1Erectile Dysfunction
01/2020
1Human Influenza (Influenza)
01/2019
1Pharyngitis (Sore Throat)
01/2019
1Bronchitis
01/2019
1Pneumonia (Pneumonitis)
01/2019
1Urinary Tract Infections (Urinary Tract Infection)
11/2017
1Albuminuria
01/2017

Drug/Important Bio-Agent (IBA)

28RNA (Ribonucleic Acid)IBA
01/2024 - 03/2005
10VaccinesIBA
01/2022 - 10/2010
7Antiviral Agents (Antivirals)IBA
01/2024 - 10/2015
6Opioid Analgesics (Opioids)IBA
11/2023 - 01/2014
5AntibodiesIBA
02/2024 - 01/2019
4Hepatitis C AntibodiesIBA
01/2016 - 03/2011
3insulin receptor-related receptor (IRR)IBA
01/2024 - 01/2023
3Immunoglobulin G (IgG)IBA
01/2023 - 01/2018
3Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2021 - 01/2018
2tenofovir diphosphateIBA
11/2023 - 11/2017
2Neutralizing AntibodiesIBA
01/2022 - 01/2018
2Proteins (Proteins, Gene)FDA Link
11/2021 - 01/2017
2AntigensIBA
01/2021 - 08/2020
2Indicators and Reagents (Reagents)IBA
11/2019 - 06/2012
2Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 08/2010
2EpitopesIBA
01/2019 - 01/2017
2Antihypertensive Agents (Antihypertensives)IBA
01/2018 - 01/2016
2Tenofovir (Viread)FDA Link
11/2017 - 01/2017
2Broadly Neutralizing AntibodiesIBA
01/2017 - 01/2016
2Interferon LambdaIBA
01/2016 - 11/2014
2Heroin (Diamorphine)IBA
09/2014 - 08/2005
2Methadone (Dolophine)FDA LinkGeneric
01/2014 - 09/2007
1Complement System Proteins (Complement)IBA
02/2024
1Interferon Type IIBA
02/2024
1Monoclonal AntibodiesIBA
02/2024
1CytokinesIBA
02/2024
1Complement Receptors (Complement Receptor)IBA
02/2024
1Cocaine (Cocaine HCl)IBA
11/2023
1Leukocyte Elastase (Neutrophil Elastase)IBA
10/2023
1Oxygen (Dioxygen)IBA
06/2023
1remdesivirIBA
06/2023
1Adrenal Cortex Hormones (Corticosteroids)IBA
06/2023
1Carbon MonoxideIBA
01/2023
1N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA
01/2023
1BNT162 VaccineIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1mRNA VaccinesIBA
01/2022
13- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA
01/2022
1altersolanol AIBA
11/2021
1ORALIT (ORS)IBA
11/2021
1HIV AntibodiesIBA
01/2021
1Anti-Idiotypic AntibodiesIBA
01/2021
1NitritesIBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1N 30IBA
01/2019
1LDL CholesterolIBA
01/2019
1oxidized low density lipoproteinIBA
01/2019
1Alanine (L-Alanine)FDA Link
01/2019
1Viral RNAIBA
01/2019
1Antidepressive Agents (Antidepressants)IBA
01/2018
1DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA
01/2018
1Emtricitabine (Emtriva)FDA Link
11/2017
1Retinol-Binding Proteins (Retinoid Binding Proteins)IBA
01/2017
1Phosphates (Orthophosphate)IBA
01/2017
1CreatinineIBA
01/2017
1Triglycerides (Triacylglycerol)IBA
01/2017
1AlbuminsIBA
01/2017

Therapy/Procedure

29Highly Active Antiretroviral Therapy (HAART)
01/2019 - 03/2003
27Therapeutics
01/2024 - 10/2002
12Condoms (Condom)
05/2024 - 05/2010
2Tattooing
12/2016 - 01/2011
2Enema (Enemas)
01/2012 - 02/2008
2First Aid (Aids, First)
09/2008 - 10/2002
1Chemoprevention
09/2022